Cargando…
Clustering cancers by shared transcriptional risk reveals novel targets for cancer therapy
Autores principales: | Gao, Hua, Baylis, Richard A., Luo, Lingfeng, Kojima, Yoko, Bell, Caitlin F., Ross, Elsie G., Wang, Fudi, Leeper, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115915/ https://www.ncbi.nlm.nih.gov/pubmed/35585548 http://dx.doi.org/10.1186/s12943-022-01592-y |
Ejemplares similares
-
Identifying shared transcriptional risk patterns between atherosclerosis and cancer
por: Baylis, Richard A., et al.
Publicado: (2023) -
Risk of Cancer After Diagnosis of Cardiovascular Disease
por: Bell, Caitlin F., et al.
Publicado: (2023) -
Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines
por: Ross, Elsie Gyang, et al.
Publicado: (2016) -
The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis
por: Jarr, Kai-Uwe, et al.
Publicado: (2022) -
Regarding “A Cluster-Randomized Trial to Test Sharing Histories as a Training Method for Community Health Workers in Peru”
por: Taylor, Daniel C.
Publicado: (2021)